Jecko Thachil/LinkedIn
Mar 9, 2026, 14:10
Jecko Thachil: The Journey of Protamine – From Heparin Reversal to Potential Gene Therapy Applications
Jecko Thachil, Consultant Haematologist at NHS, shared a post on LinkedIn about his recent article, adding:
“Protamine is a very useful drug in reversing heparin and has been used for several years.
How did its journey start from the discovery of DNA and now may be relevant for gene therapy?”
Title: Protamine—The Journey from DNA to Heparin Neutralization to Gene therapy
Author: Jecko Thachil
Read the Full Article on Seminars in Thrombosis and Hemostasis
Other posts featuring Jecko Thachil on Hemostasis Today.
-
Aug 14, 2026, 13:28Eduardo Medronha: DIPS as a Rescue Strategy in Budd–Chiari Syndrome
-
Aug 14, 2026, 13:18Immune Checkpoint Inhibitors Have Transformed Cancer Treatment – RPTH Journal
-
Aug 14, 2026, 13:04Mohammed M. Aboudeif: Cerebral Venous Thrombosis – Think Early, Treat Decisively
-
Aug 14, 2026, 12:49Ahmed Hawash: The Hawash Method for Managing Extreme ICU Complexity
-
Aug 14, 2026, 12:42Why Unfractionated Heparin Still Matters in Modern Anticoagulation – Thrombosis Canada
-
Aug 14, 2026, 11:40Liz Devlin: When HHT Affects More Than What We Can See
-
Aug 14, 2026, 11:29Archil Jaliashvili: Can Italy Reduce Its Dependence on Imported Plasma
-
Aug 14, 2026, 11:21Osama Alabdi: Never Ignore a Weak Reaction in the Blood Bank
-
Aug 14, 2026, 11:14Yohan Santin: How Lysosomal Dysfunction Drives Cardiac Aging